Objective: To evaluate the efficacy of None of them required exchange transfusion. Ten pentaglobulin in reducing the rate of exchange newborns required top up transfusion. The transfusion among neonates with immune duration of phototherapy application ranged from hemolytic anaemia.
INTRODUCTION
of bilirubin continued to be high. The maximum Isoimmune hemolytic jaundice due to ABO and Rh doses we used were three doses for three days. We blood group incompatibility is an important used the blue light and double phototherapy 1 problem in the neonatal period. Exchange technique for all newborns with significant transfusion and phototherapy have traditionally jaundice. been the primary modes of treatment to reduce both We limited our study to newborns with immune 2 mortality and the risk of kernicterus. Recent hemolytic anaemia (Rh; ABO or minor blood group attention has turned to therapies aimed at reducing incompatibilities) who had jaundice in their first day the need for exchange transfusion. New therapies of life with levels requiring phototherapy or had a include haem oxygenase inhibitors and intravenous rising level of bilirubin > 0.5 mg/ hr; and newborns immunoglobulin (IVIG). IVIG treatment in who came back to hospital with high bilirubin level isoimmune jaundice has been shown to be effective, requiring intensive light or approaching exchange 3 but the response to treatment is variable. The aim of transfusion. this study was determine effect of pentaglobin on exchange transfusion and the duration of RESULTS phototherapy application.
During the study period we admitted 85 newborns with significant jaundice secondary to immune METHODOLOGY hemolytic anemia. Ten infants had Rh The observational study was performed in the incompatibility to Rh negative mothers and had neonatal unit at King Hussein Medical Center positive direct combs test; 70 had ABO Amman, Jordan over two year period from January incompatibility and 5 cases had minor blood groups 2010 to January 2012. Pentaglobulin (Biotest) is i n c o m p a t i b i l i t i e s . M i n o r b l o o d g r o u p human plasma protein with 95% globulin and was incompatibility is diagnosed when there is no Rh or used as a substitute for IVIG. One ml contains 50 mg ABO incompatibility but the direct combs test is (IgG 38 mg; IgM 6 mg; IgA 6 mg). We gave it in a positive. ABO incompatibility is diagnosed when dose of 1gm/Kg/ day by slow intravenous infusion the mother blood group is O and the newborn is A, B, at a rate of 1.7 ml/Kg/hr as recommended by the or AB and the direct combs test is positive. Seventy manufacture. A single dose was used unless the level newborns were admitted in their first 24 hours of life (average time 18 hours) and 15 were admitted in IVIG treatment appeared to be better at blocking 9 their second day (average time 35 hours).
ongoing hemolysis, while others did not show 2 reduced need for exchange transfusion. All the There was no significant rise in the level of bilirubin reviewed studies used IVIG but not pentaglobulin. (< 0.5 mg/hour) in 73 (86%) newborns and required
In our observation we found that pentaglobulin was only one dose of pentaglobulin; twelve newborns effective in reducing the rate of exchange required two doses because they continued to have trsnsfusion and the duration of phototherapy high level of bilirubin; eight of these twelve application among neonates with immune newborns had Rh incompatibility and four had ABO hemolytic anemia. Further randomized trials are incompatibility needed to confirm our observations. (mothers had O blood group and their infants had B blood group ). CONCLUSION In 60 cases we could stop phototherapy after 48 hours without significant rebound of bilirubin level; Pentaglobulin could be effective in reducing the rate 20 newborns required phototherapy for 72 hours and of exchange transfusion in neonatal immune 5 for 84 hours. None of the 85 newborns required hemolytic jaundice and the duration of exchange transfusion but 10 infants (12%) required phototherapy application. top up transfusions on their third day of life. They were the newborns who required two doses of pentaglobulin and phototherapy for three days. We did not record any side effects during pentaglobulin infusion. REFERENCES later. Some studies showed that multiple doses
